Xeris Pharmaceuticals Inc Capital Reinvestment Ratio
Xeris Pharmaceuticals Inc capital reinvestment ratio. Xeris Pharmaceuticals Inc (XERS) has a Capital Reinvestment Ratio of 0.03x as of June 2026, meaning it reinvests 0% of its operating cash flow ($8.26 Million) in capital expenditures ($209.00K). Check total reinvestment intensity of Xeris Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Xeris Pharmaceuticals Inc (2025–2025)
Capital reinvestment ratio of Xeris Pharmaceuticals Inc from 2025 to 2025. This chart tracks Xeris Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore XERS year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Xeris Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2025–2025)
Xeris Pharmaceuticals Inc capital reinvestment ratio by year from 2025 to 2025. For the full cash flow conversion analysis, see XERS cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | $28.63 Million | $696.00K | — |